A Meta-analysis of Factors Impacting Detection of Antidepressant Efficacy in Clinical Trials: The Importance of Academic Sites
Boadie W. Dunlop(Emory University), Philip T. Ninan(Emory University), Christine J. Guico‐Pabia(Pfizer (United States)), Jeff Musgnung(Pfizer (United States)), Michael E. Thase(Veterans Health Administration), Chuan‐Chuan Wun(Pfizer (United States)), Rana Fayyad(Pfizer (United States))
Cited by 74
Related Papers
The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression
|Biological Psychiatry|2003|3.9k
A Comparison of Nefazodone, the Cognitive Behavioral-Analysis System of Psychotherapy, and Their Combination for the Treatment of Chronic Depression
|New England Journal of Medicine|2000|1.3k
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design
|Controlled Clinical Trials|2004|1.1k
Frontiers of cognitive therapy
|General Hospital Psychiatry|1997|1.1k